BRCA1 and prostate carcinoma: Castro et al. reported on 79 patients with prostate cancer who were positive for a BRCA1/2 mutation and found that these patients frequently presented with higher Gleason scores (≥ 8), higher T stage (T3 or T4), nodal involvement and metastases at diagnosis [12].